The University of Tokyo · Institute of Medical Science

Research keywordsesophageal cancer・neoadjuvant chemotherapy・salivary gland carcinoma・pegfilgrastim・histopathological response・head and neck pathology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Relationship Between Short-Term Outcomes and PD-L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti-PD-1 Antibody Monotherapy.
• Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses.
• A Rare Case of Adult Poorly Differentiated Chordoma of the Skull Base With Rapid Progression and Systemic Metastasis: A Review of the Literature.
• Successful use of anti-PD-1 antibody to treat multiple metastatic carcinomas in a patient with xeroderma pigmentosum: case report and literature review

• Official profile